Inventor · disambiguated record
Ramesh Bhatt
Also filed as: BHATT RAMESH · BHATT RAMESH R · BHATT RAMESH RAJANI
17 granted patents·39 pending applications·155 citations·filing 1993–2025
91Inventor score
Files withHOROWITZ LAWRENCE14JANUX THERAPEUTICS INC11SEA LANE BIOTECHNOLOGIES LLC6BHATT RAMESH4I2 PHARMACEUTICALS INC4
Top patents by PatentIndex Score
56 records- 0194US8114967B2Constructs and libraries comprising antibody surrogate light chain sequencesBHATT RAMESH·Filed 2008·Granted Feb 14, 2012·76 cites·1 claims
- 0289US9169318B2Neutralizing molecules to viral antigensHOROWITZ LAWRENCE·Filed 2011·Granted Oct 27, 2015·8 cites·11 claims
- 0388US12161724B2Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigensJANUX THERAPEUTICS INC·Filed 2022·Granted Dec 10, 2024·1 cites·21 claims
- 0484US8716195B2Antibody ultrahumanization by predicted mature CDR blasting and cohort library generation and screeningCAPPUCCILLI GUIDO·Filed 2006·Granted May 6, 2014·12 cites·2 claims
- 0584US8131480B2Construction of diverse synthetic peptide and polypeptide librariesHOROWITZ LAWRENCE·Filed 2007·Granted Mar 6, 2012·5 cites·18 claims
- 0680US12433953B2Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigensJANUX THERAPEUTICS INC·Filed 2024·Granted Oct 7, 2025·0 cites·31 claims
- 0778US10759855B2Antigen binding molecules to TIGITRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 1, 2020·1 cites·9 claims
- 0878US5512435AReceptor-binding antiproliferative peptidesFiled 1993·Granted Apr 30, 1996·51 cites·9 claims
- 0978US2025127793A1Conjugates of surrogate light chain constructsREVOPSIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1078US2024376226A1Compositions and methods relating to tumor activated t cell engagersJANUX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1174US8148085B2Donor specific antibody librariesHOROWITZ LAWRENCE·Filed 2007·Granted Apr 3, 2012·1 cites·18 claims
- 1270US2023270854A1Modified antibodiesJANUX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1365US2012129731A1Design and construction of diverse synthetic peptide and polypeptide librariesHOROWITZ LAWRENCE·Filed 2011·Application pending·0 cites
- 1463US10214580B2Constructs and libraries comprising antibody surrogate light chain sequencesI2 PHARMACEUTICALS INC·Filed 2013·Granted Feb 26, 2019·0 cites·2 claims
- 1563US2010040635A1Neutralizing antibodies to influenza virusesSea Lane Biotechnologies·Filed 2009·Application pending·0 cites
- 1662US2023220105A1Tumor activated t cell engagers and methods of use thereofJANUX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1762US2021380703A1Acvr2a-specific antibody and method of use thereofRIGEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1862US2023220109A1Compositions and methods relating to tumor activated t cell engagersJANUX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1961US2008014205A1Neutralizing Antibodies to Influenza VirusesHOROWITZ LAWRENCE·Filed 2007·Application pending·0 cites
- 2061US2010291066A1Donor specific antibody librariesSEA LANE BIOTECHNOLOGIES LLC·Filed 2008·Application pending·0 cites
- 2161US2014205614A1Neutralizing antibodies to influenza virusesSEA LANE BIOTECHNOLOGIES LLC·Filed 2013·Application pending·0 cites
- 2260US2012107326A1Neutralizing antibodies to influenza virusesHOROWITZ LAWRENCE·Filed 2011·Application pending·0 cites
- 2360US2020339678A1Antigen binding molecules to tigitRIGEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2459US11104737B2ACVR2A-specific antibody and method of treatment of muscle atrophyRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Aug 31, 2021·0 cites·17 claims
- 2558US2024254241A1Antibodies targeting egfr and cd3 and uses thereofJANUX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2658US2012264647A1Donor specific antibody librariesHOROWITZ LAWRENCE·Filed 2012·Application pending·0 cites
- 2758US2018339043A1Modified antibodiesJANUX THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2856US2024034814A1Half-life extending compositions and methodsJANUX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2956US2012202713A1Constructs and libraries comprising antibody surrogate light chain sequencesBHATT RAMESH·Filed 2012·Application pending·0 cites
- 3055US2017136118A1Neutralizing molecules to viral antigensSEA LANE BIOTECHNOLOGIES INC·Filed 2016·Application pending·0 cites
- 3154US2010004134A1Combinatorial libraries of conformationally constrained polypeptide sequencesHOROWITZ LAWRENCE·Filed 2008·Application pending·0 cites
- 3254US2021115106A1Modified t cell receptorsJANUX THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3354US2020385440A1Modified bispecific t cell receptorsJANUX THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3453US2019127482A1Conjugates of surrogate light chain constructsI2 PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3552US10216897B2Construction of diverse synthetic peptide and polypeptide librariesI2 PHARMACEUTICALS INC·Filed 2016·Granted Feb 26, 2019·0 cites·21 claims
- 3652US10017561B2Neutralizing molecules to influenza viruses12 PHARMACEUTICALS INC·Filed 2015·Granted Jul 10, 2018·0 cites·11 claims
- 3751US2009215639A1Method of Producing Human IgG Antibodies with Enhanced Effector FunctionsBIOREN INC·Filed 2006·Application pending·0 cites
- 3850US2010316654A1Neutralizing antibodies to influenza virusesHOROWITZ LAWRENCE·Filed 2010·Application pending·0 cites
- 3949US2012107871A1Method of producing human igg antibodies with enhanced effector functionsCREA ROBERTO·Filed 2011·Application pending·0 cites
- 4049US2015011736A1Binding molecule conjugatesSEA LANE BIOTECHNOLOGIES LLC·Filed 2013·Application pending·0 cites
- 4147US8969082B2Expression of surrogate light chainsHOROWITZ LAWRENCE·Filed 2010·Granted Mar 3, 2015·0 cites·22 claims
- 4247US2010233167A1Chain reaction creating oligomers from repeat units of binding moleculesBHATT RAMESH·Filed 2008·Application pending·0 cites
- 4347US2013288900A1Combinatorial libraries of conformationally constrained polypeptide sequencesHOROWITZ LAWRENCE·Filed 2011·Application pending·0 cites
- 4446US2009098164A1Spore associated displayBHATT RAMESH·Filed 2008·Application pending·0 cites
- 4545US2010062950A1Constructs and libraries comprising antibody surrogate kappa light chain sequencesBHATT RAMESH R·Filed 2009·Application pending·0 cites
- 4644US9975956B2Surrogate binding proteins which bind DR4 and/or DR5I2 PHARMACEUTICALS INC·Filed 2012·Granted May 22, 2018·0 cites·15 claims
- 4744US2012128671A1Neutralizing molecules to influenza virusesHOROWITZ LAWRENCE·Filed 2010·Application pending·0 cites
- 4844US2016354486A1Binding molecule conjugatesSEA LANE BIOTECHNOLOGIES LLC·Filed 2015·Application pending·0 cites
- 4942US2007224627A1Facilitation of translocation of molecules through the gastrointestinal tractHOROWITZ LAWRENCE·Filed 2007·Application pending·0 cites
- 5041US2012269830A1Conjugates with improved pharmacokinetic propertiesHOROWITZ LAWRENCE·Filed 2010·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ramesh Bhatt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →